Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J J Godfroid

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
Journal of Medicinal Chemistry|January 1, 1975
Quantitative structure-activity relationships for dicoumarol antivitamins K in the uncoupling of mitochondrial oxidative phosphorylationC Laruelle, J J Godfroid
Comptes Rendus De L'Academie Des Sciences. Serie III, Sciences De La Vie|January 1, 1985
[Metabolic activity of 3-hydroxymethyl N-methyl piperidine (4-chlorophenoxy) acetate hydrochloride in obese rats]F Massicot, E Steiner, J J Godfroid
Comptes Rendus De L'Academie Des Sciences. Serie III, Sciences De La Vie|January 1, 1984
[Effect of 3-hydroxymethyl-N-methylpiperidine (4-chlorophenoxyacetate) hydrochloride on feeding behavior. Toxicity and neuropsychopharmacology]F Massicot, J Thuillier, J J Godfroid
Comptes Rendus De L'Academie Des Sciences. Serie III, Sciences De La Vie|January 1, 1986
[Lipolytic effects of 3-(hydroxymethyl)-N-methylpiperidine (4-chlorophenoxy)-acetate HCl]F Massicot, R Falcou, E Steiner, et al.
International Journal of Obesity|January 1, 1985
Activation of energy expenditure in the rat by a new non-amphetaminic compound: the (4-chlorophenoxyacetate) N-methyl 3-hydroxymethyl piperidine, hydrochloride (PM 170)F Massicot, D Ricquier, J J Godfroid, et al.
Journal of Lipid Mediators|September 1, 1989
PAF receptor. 2. Quantitative hydrophobic contribution of the agonist's etheroxid chainF Heymans, E Steiner, S Jouquey, et al.
Journal of Medicinal Chemistry|February 1, 1980
Quantitative structure-activity relationships for N-[N',N'-disubstituted-amino)acetyl]arylamines for local anesthetic activity and acute toxicityF Heymans, L Le Thérizien, J J Godfroid, et al.
General Pharmacology|January 1, 1987
Effects of a new anorectic drug (PM 170) on development of gold thioglucose-induced obesity in miceF Massicot, R Falcou, F Heymans, et al.
Comptes Rendus De L'Academie Des Sciences. Serie III, Sciences De La Vie|January 1, 1986
[Anti-obesity activity of 3-hydroxymethyl N-methyl piperidine 4-chlorophenoxyacetate hydrochloride in mice treated with gold thioglucose]F Massicot, G Arapis, R Falcou, et al.
Acta Crystallographica. Section C, Crystal Structure Communications|July 15, 1991
Platelet activating factor antagonists. Structure of N,N'-bis(3,4,5-trimethoxybenzoyl)-2-piperazinylmethyl 2,2-dimethylpropanoateJ B Stensland, J P Batt, A Lamouri, et al.
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Journal of Medicinal Chemistry|January 1, 1975
Quantitative structure-activity relationships for dicoumarol antivitamins K in the uncoupling of mitochondrial oxidative phosphorylationC Laruelle, J J Godfroid
Comptes Rendus De L'Academie Des Sciences. Serie III, Sciences De La Vie|January 1, 1985
[Metabolic activity of 3-hydroxymethyl N-methyl piperidine (4-chlorophenoxy) acetate hydrochloride in obese rats]F Massicot, E Steiner, J J Godfroid
Comptes Rendus De L'Academie Des Sciences. Serie III, Sciences De La Vie|January 1, 1984
[Effect of 3-hydroxymethyl-N-methylpiperidine (4-chlorophenoxyacetate) hydrochloride on feeding behavior. Toxicity and neuropsychopharmacology]F Massicot, J Thuillier, J J Godfroid
Comptes Rendus De L'Academie Des Sciences. Serie III, Sciences De La Vie|January 1, 1986
[Lipolytic effects of 3-(hydroxymethyl)-N-methylpiperidine (4-chlorophenoxy)-acetate HCl]F Massicot, R Falcou, E Steiner, et al.
International Journal of Obesity|January 1, 1985
Activation of energy expenditure in the rat by a new non-amphetaminic compound: the (4-chlorophenoxyacetate) N-methyl 3-hydroxymethyl piperidine, hydrochloride (PM 170)F Massicot, D Ricquier, J J Godfroid, et al.
Journal of Lipid Mediators|September 1, 1989
PAF receptor. 2. Quantitative hydrophobic contribution of the agonist's etheroxid chainF Heymans, E Steiner, S Jouquey, et al.
Journal of Medicinal Chemistry|February 1, 1980
Quantitative structure-activity relationships for N-[N',N'-disubstituted-amino)acetyl]arylamines for local anesthetic activity and acute toxicityF Heymans, L Le Thérizien, J J Godfroid, et al.
General Pharmacology|January 1, 1987
Effects of a new anorectic drug (PM 170) on development of gold thioglucose-induced obesity in miceF Massicot, R Falcou, F Heymans, et al.
Comptes Rendus De L'Academie Des Sciences. Serie III, Sciences De La Vie|January 1, 1986
[Anti-obesity activity of 3-hydroxymethyl N-methyl piperidine 4-chlorophenoxyacetate hydrochloride in mice treated with gold thioglucose]F Massicot, G Arapis, R Falcou, et al.
Acta Crystallographica. Section C, Crystal Structure Communications|July 15, 1991
Platelet activating factor antagonists. Structure of N,N'-bis(3,4,5-trimethoxybenzoyl)-2-piperazinylmethyl 2,2-dimethylpropanoateJ B Stensland, J P Batt, A Lamouri, et al.
Pageof 5